Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
NEWTOWN, Pa., March 06, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, after the market closes.
Related news for (HSDT)
- Dealmaking Drives the Tape: These Stocks Are Heating Up into the Close
- Capital Meets Conviction: VENU, HSDT, GLUE, and IHT Show Investors the Money
- MoBot alert highlights: NASDAQ: HSDT, NASDAQ: RCEL, NYSE: GPUS, NYSE: ATCH, NASDAQ: HYFT (09/15/25 06:00 AM)
- MoBot alert highlights: NYSE: ATCH, NASDAQ: HSDT, NASDAQ: HYFT, NASDAQ: HAIN, NASDAQ: BTBD (09/15/25 05:00 AM)
- Today’s Top Performers: MoBot’s Market Review 09/15/25 04:00 AM